After Its Drop, Is Aurinia Stock Now A Buy?
Aurinia Pharmaceuticals (NASDAQ:AUPH) could eventually change how doctors treat kidney failure in lupus patients. If so, buying shares, which have fallen significantly from their peak in March, could prove profit-friendly. Is this stock about to go higher?